QUALITATIVE RESEARCHUncovering a new therapeutic area for an existing medication with a unique mechanism of action
SITUATION
As part of life cycle management activities for a successful medication, our client is exploring the potential of several new indications for incremental clinical trial investment.
One of these indications is an ultra-rare disease that affects several organ systems and features poorly defined diagnostic and treatment guidelines.
APPROACH
Collect and synthesize internal information from medical affairs, precision medicine, competitive intelligence and forecasting cross-functional teams
Supplement existing information with extensive desk research leveraging some 25 different resources
Execute qualitative research (physician IDIs) to clarify information gaps that remained
RESULTS
The research:
Defined the disease as well as unmet treatment needs and provided estimates of market size/likely growth
Outlined a complicated origination, referral, diagnostic and treatment path including the outlining HCP roles, patient experiences and payor perceptions
Incorporated competitive intelligence and forecasting estimates
IMPACT
Client used the research to:
Present disease area viability for additional investment
Provide insights to inform initial disease area strategy
Introduce the disease, provide education to cross-functional stakeholders, global affiliates